Head Engineering expects revenue of SEK 450–600 million in 2026
Head Engineering clarifies its previously communicated assessment and expects revenue of SEK 450–600 million for the full year 2026, with an unchanged operating margin of approximately 25 percent. The company’s order backlog amounted to approximately SEK 1.5 billion at the end of June, while revenue during the first half of the year amounted to SEK […]
Brazil’s stock market plunges more than 16 percent after Lula’s election victory
Brazil’s Ibovespa stock index plunged more than 16 percent to below 172,000 on Monday after President Lula defeated Flávio Bolsonaro in the second round of the presidential election. The decline is driven by concerns over increased public spending, continued budget deficits and rising government debt. Brazil is South America’s largest economy. Petrobras fell 16 percent, […]
Confirmed: Anthropic files for IPO – has grown by 1,300 percent (update 2)
(corrects spelling error in headline) It is now confirmed that AI company Anthropic is targeting the stock market. This follows the company making public its filing with Nasdaq under the ticker ANT, according to a prospectus. Bloomberg News was first to report the information. The company originally filed a confidential application with the U.S. Securities […]
Confirmed: Anthropic files for IPO – has grown by 1,300 percent (update)
(information on the company’s financial performance during H1) It is now confirmed that AI company Anthropic is targeting a stock market listing. This follows the company’s disclosure of its application with Nasdaq under the ticker ANT, according to an IPO prospectus. Bloomberg News was first to report the information. The company originally filed a confidential […]
US pre-market: Lumentum rises most among Nasdaq 100 stocks
Pre-market quotes with a 15-minute delay. 10 biggest gainers% change, todayLumentum Holdings+3,05%Ross Stores+2,92%Tesla+2,47%Micron Technology+2,18%Astera Labs+2,06%Teradyne+1,99%Western Digital+1,84%Seagate Technology+1,80%Monolithic Power Systems+1,78%Lam Research+1,64%10 biggest losers% change, todayMercadoLibre−15,20%Moderna−7,05%CoreWeave−4,75%Nebius Group−2,36%Strategy−1,96%Alnylam Pharmaceuticals−1,35%Apple−1,25%PayPal Holdings−1,07%DoorDash−0,91%Meta Platforms−0,87%Source: Factset
Nordea repeats Hold rating on Bakkafrost – sees pressure from feed costs
Nordea repeats its Hold rating on salmon-farming company Bakkafrost with a price target of NOK 500. Ahead of the third quarter, the bank expects operating EBIT of DKK 194 million, slightly below consensus. Operations in Scotland are expected to remain under pressure, while the Faroe Islands are expected to show improvements compared with the previous […]
Episurf enters letter of intent to divest medical technology business
Episurf Medical has entered a letter of intent with Canadian Oligo Medic regarding a possible divestment of the company’s medical technology business, according to a press release. The letter of intent is part of the company’s streamlining towards real estate operations. The parties will now continue working on the transaction structure and a possible final […]
Cellavision expected to report EBITDA of SEK 57 million – Factset
The blood analysis company Cellavision will release its report for the third quarter on Thursday. Expected EBITDA, according to Factset consensus based on estimates from four analysts, is SEK 57 million. In the corresponding period last year, the result was SEK 50 million. The company will release the report at 07.20 and hold a conference […]
Nordea and BofA warn of margin pressure at Autoliv
Nordea repeats its Hold rating on automotive safety company Autoliv with a price target of SEK 1,070, while Bank of America repeats its Buy rating but lowers its price target to USD 125 from USD 134, corresponding to approximately SEK 1,241. Both banks point out that adjusted operating profit in Q3 exceeded expectations, partly thanks […]
Episurf enters into a letter of intent to divest its medtech business
Episurf enters into a letter of intent to divest its medtech business
